市场调查报告书
商品编码
1497617
心血管导管市场:按导管、按应用、按最终用户划分 - 2024-2030 年全球预测Cardiovascular Catheters Market by Catheters (Electrophysiology Catheters, Guide Extension Catheter, Intravascular Ultrasound Catheters), Usability (Disposable, Reusable), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年心血管导管市场规模为127.9亿美元,预计2024年将达137.1亿美元,2030年将达211亿美元,复合年增长率为7.41%。
心血管导管是一种专门的医疗设备,设计用于在血管内导航以执行涉及心臟和心血管系统其他部分的治疗和诊断程序。它是一种长而细的管状装置,在影像引导下透过循环系统引导指定。随着世界各地受心血管疾病影响的人数不断增加,对心血管导管等有效诊断和治疗解决方案的需求日益增长。政府努力提高人们对心臟健康和心臟病的认识,再加上诊所、医院、外科和诊断中心的扩张,正在加速心血管导管等关键医疗设备的采用。然而,导管插入术技术复杂,需要高技能的专业人员,这可能会限制在缺乏专业医疗人员的地区进行此类手术。性能和安全性问题,例如感染和污染的风险以及设备故障,可能会引起人们对心血管导管可靠性的担忧。导管技术的创新,例如开发更灵活和耐用的材料以及提高基于导管的干预措施的精度,可以扩大心臟病治疗的范围和有效性。
主要市场统计 | |
---|---|
基准年[2023] | 127.9亿美元 |
预测年份 [2024] | 137.1亿美元 |
预测年份 [2030] | 211亿美元 |
复合年增长率(%) | 7.41% |
区域洞察
由于饮食和生活方式的变化以及人口老化,美洲地区心血管疾病的盛行率很高,特别是在美国和加拿大。美洲的医疗保健提供者越来越多地采用先进技术来管理心血管疾病,增加了对先进心血管导管进行诊断和治疗的需求。研究和开发投资得到私人和公共资金的支持。该地区最近的专利主要集中在导管耐用性和诊断准确性方面的创新。欧盟国家受益于完善的医疗保健系统和统一的监管标准,这有助于获得和实施包括心血管导管在内的新医疗技术。重点在于提高心血管导管的亲和性,研发工作正在积极进行。在亚太地区,由于人口老化的增加和文明病的蔓延,中国和日本对心血管导管的需求不断增加。在政府旨在整合更先进医疗技术的措施的支持下,亚太地区国家正在迅速扩大其医疗保健基础设施。农村和偏远地区医疗保健设施的扩张以及医疗设备本地製造的促进将促进亚太地区心血管导管的成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在心血管导管市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对心血管导管市场供应商的现况进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在心血管导管市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[198 Pages Report] The Cardiovascular Catheters Market size was estimated at USD 12.79 billion in 2023 and expected to reach USD 13.71 billion in 2024, at a CAGR 7.41% to reach USD 21.10 billion by 2030.
Cardiovascular catheters are specialized medical devices designed for navigating through blood vessels to deliver therapies or perform diagnostic procedures relating to the heart and other parts of the cardiovascular system. They are slender, tube-like instruments that are guided into place through the circulatory system under imaging guidance. With increasing numbers of individuals affected by cardiovascular conditions worldwide, there is a growing need for effective diagnostic and therapeutic solutions such as cardiovascular catheters. Government initiatives to raise awareness for heart health and heart conditions, coupled with the expansion of clinics, hospitals, and surgical and diagnostics centers, have accentuated the adoption of critical medical devices such as cardiovascular catheters. However, the technical complexity of catheterization requires highly skilled professionals, which can restrict the availability of these procedures in regions with shortages of specialized healthcare providers. Performance and safety issues such as risks of infection and contamination and malfunctioning of the device can raise concerns about the reliability of cardiovascular catheters. Innovations in catheter technology, including the development of more flexible and durable materials, as well as enhancements in the precision of catheter-based interventions, can expand the scope and effectiveness of treatments available for heart diseases.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 12.79 billion |
Estimated Year [2024] | USD 13.71 billion |
Forecast Year [2030] | USD 21.10 billion |
CAGR (%) | 7.41% |
Regional Insights
In the Americas, particularly the United States and Canada, there is a high prevalence of cardiovascular diseases owing to dietary and lifestyle changes and an aging population. Healthcare providers in the Americas region are increasingly adopting advanced technologies for managing cardiovascular conditions, driving the need for sophisticated cardiovascular catheters for diagnosis and treatment. Investment in research and development is robust, supported by both private and public funding. Recent patents in the region have focused on innovations in catheter durability and the precision of diagnostic features. EU countries benefit from well-established healthcare systems and uniform regulatory standards, which enhance the accessibility and adoption of new medical technologies, including cardiovascular catheters. There is a heightened focus on improving the biocompatibility of cardiovascular catheters, giving rise to robust R&D initiatives. In the APAC region, China and Japan present a need for cardiovascular catheters due to large aging populations and the increasing prevalence of lifestyle diseases. APAC nations are rapidly expanding their healthcare infrastructure, supported by governmental initiatives aimed at incorporating more advanced medical technologies. The expansion of healthcare facilities in rural and remote locations and a heightened emphasis on advancing local manufacturing of medical devices provide a conducive framework for the growth of cardiovascular catheters in the APAC region.
Market Insights
The market dynamics represent an ever-changing landscape of the Cardiovascular Catheters Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiovascular Catheters Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiovascular Catheters Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Cook Medical Partners with Bentley to Distribute BeBack Crossing Catheter in the USA
Cook Medical has entered into a distribution agreement with Bentley to market the BeBack crossing catheter in the United States, enhancing Cook's peripheral intervention portfolio. This collaboration enables greater access to the BeBack device, which is essential for navigating chronic total occlusions (CTO) and facilitating precise re-entry, particularly in heavily calcified lesions. [Published On: 2024-03-21]
Introduction of the Micro Rx Microcatheter by Biotronik, Enhancing Guidewire Support in Percutaneous Coronary Interventions
Biotronik has introduced the Micro Rx microcatheter in the USA, a cutting-edge device designed to improve guidewire support during percutaneous coronary interventions (PCI). This rapid exchange microcatheter, the fourth product from Interventional Medical Device Solutions (IMDS) distributed by Biotronik in the U.S. market, features a robust design with a reinforced distal shaft and a core wire sandwiched between two braiding layers to ensure efficient push transfer. I [Published On: 2024-02-08]
Introduction of Enhanced Shockwave C2+ Catheter Promises Improved Cardiovascular Treatment
Shockwave Medical is set to introduce its advanced Shockwave C2+ coronary intravascular lithotripsy (IVL) catheter at the Transcatheter Cardiovascular Therapeutics (TCT) symposium. The C2+ catheter aims to improve procedural efficiency and is already marketed for treating de novo coronary artery disease in the U.S., Europe, and other regions. The company highlighted the device's enhanced capacity to treat complex calcium cases in cardiovascular procedures including diffuse disease and eccentric calcifications. [Published On: 2023-10-20]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiovascular Catheters Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cardiovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics Inc., Asahi Intecc Co., Ltd., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corp., Cardinal Health, Coloplast Corp., Cook Group Incorporated, Cordis Corporation, Edwards Lifesciences, Getinge AB, Infraredx by Nipro Corp., Integer Holdings Corp., Johnson & Johnson Services, Inc., McKesson Medical-Surgical Inc., Medtronic PLC, Merit Medical Systems, Microport Scientific Corp., Penumbra, Inc., Smith+Nephew PLC, Stryker Corporation, Teleflex Inc., and Terumo Corporation.
Market Segmentation & Coverage